Table 4

Clinicopathological parameters and responses to chemotherapy with urine TFF3 in colorectal cancer patients
Item Cases (n) Urine TFF3 (ng/ml) P-value
Age
 ≤60 37 5.71 ± 0.94 0.088
 >60 20 3.99 ± 0.89
Gender
 Male 37 5.17 ± 0.93 0.558
 Female 20 6.04 ± 1.03
Site
 Colon 38 4.84 ± 0.64 0.201
 Rectum 19 6.75 ± 1.66
Degree of differentiation
 Well-moderately 47 5.67 ± 0.84 0.558
 Poorly 10 4.58 ± 0.56
Stage (I-III VS IV) 0.222
 I-II 9 3.72 ± 1.16
 III 11 4.60 ± 1.58
 IV 37 6.16 ± 0.92
Lymphatic metastasis
 N(-) 9 2.92 ± 1.00 0.164
 N(+) 14 5.57 ± 1.32
Distant metastasis
 M0 20 4.20 ± 0.99 0.184
Responses to chemotherapy
 PR 8
  Befor-chemo 9.18 ± 3.06 0.076
  After-chemo 3.06 ± 0.93
 SD 17
  Befor-chemo 5.95 ± 1.16 0.76
  After-chemo 8.83 ± 3.35
 PD 4
  Befor-chemo 3.26 ± 0.87 0.13
  After-chemo 9.87 ± 3.68

Xiao et al.

Xiao et al. BMC Clinical Pathology 2014 14:26   doi:10.1186/1472-6890-14-26

Open Data